Public Citizen wants withdrawal of diabetes drug
WASHINGTON - April 19, 2012 (WPVI) -- A consumer advocacy group is calling on government regulators to withdraw a diabetes drug from Novo Nordisk, saying the injectable medication raises the risk of thyroid cancer, pancreatitis and kidney failure.
Public Citizen is sending a petition to the Food and Drug Administration saying the risks of Victoza far outweigh its benefits as a diabetes drug, a crowded field that includes nearly a dozen similar medications.
Citing internal agency documents, the group notes that FDA approved the drug in 2010 against the recommendation of three staff scientists.
Any citizen or group can petition the FDA to remove a product from the market based on safety, economic or environmental reasons. The FDA often takes months or even years to render a decision on such requests.
prescriptions, diabetes, healthcheck
- Police: Missing boy struck by car
- Temps soar above normal
- WATCH: Action News Online
- 2013 Troop Greetings
- Coffins unearthed at North Philly school
- No jackets for North Philadelphia cheer squad
- Attack in Center City caught on camera
- Police: Threat to father used in phone scam
- Stolen cobalt-60 found abandoned in Mexico
- Report: NSA tracks billions of cellphones daily
- Kutztown coach accused of covering up teen's rape
- Prosecutor: Sex investigation of FSU QB over
- Photos: 6abc at Q102 Jingle Ball 2013
- Video: 20th annual Phila. holiday tree lighting